These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34572746)

  • 1. The Tumor Microenvironment-Dependent Transcription Factors AHR and HIF-1α Are Dispensable for Leukemogenesis in the Eµ-TCL1 Mouse Model of Chronic Lymphocytic Leukemia.
    Gonder S; Largeot A; Gargiulo E; Pierson S; Fernandez Botana I; Pagano G; Paggetti J; Moussay E
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons learned from the Eµ-TCL1 mouse model of CLL.
    Floerchinger A; Seiffert M
    Semin Hematol; 2024 Jun; 61(3):194-200. PubMed ID: 38839457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment.
    Valsecchi R; Coltella N; Belloni D; Ponente M; Ten Hacken E; Scielzo C; Scarfò L; Bertilaccio MT; Brambilla P; Lenti E; Martinelli Boneschi F; Brendolan A; Ferrero E; Ferrarini M; Ghia P; Tonon G; Ponzoni M; Caligaris-Cappio F; Bernardi R
    Blood; 2016 Apr; 127(16):1987-97. PubMed ID: 26825709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD74 is dispensable for development of chronic lymphocytic leukemia in
    Barthel R; Fedorchenko O; Velmans T; Rosen N; Nguyen PH; Reinart N; Florin A; Herling M; Hallek M; Fingerle-Rowson G
    Leuk Lymphoma; 2020 Dec; 61(12):2799-2810. PubMed ID: 32667245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD73 Promotes Chronic Lymphocytic Leukemia.
    Allard D; Chrobak P; Bareche Y; Allard B; Tessier P; Bergeron MA; Johnson NA; Stagg J
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the splenic microenvironment in chronic lymphocytic leukemia development in Eµ-TCL1 transgenic mice.
    Collard JP; McKenna MK; Noothi SK; Alhakeem SS; Rivas JR; Rangnekar VM; Muthusamy N; Bondada S
    Leuk Lymphoma; 2022 Aug; 63(8):1810-1822. PubMed ID: 35258388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory T cells contribute to the immunosuppressive phenotype of neutrophils in a mouse model of chronic lymphocytic leukemia.
    Goral A; Sledz M; Manda-Handzlik A; Cieloch A; Wojciechowska A; Lachota M; Mroczek A; Demkow U; Zagozdzon R; Matusik K; Wachowska M; Muchowicz A
    Exp Hematol Oncol; 2023 Oct; 12(1):89. PubMed ID: 37817276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 regulates the apoptotic response and promotes disease development in chronic lymphocytic leukemia.
    Fedorchenko O; Stiefelhagen M; Peer-Zada AA; Barthel R; Mayer P; Eckei L; Breuer A; Crispatzu G; Rosen N; Landwehr T; Lilienthal N; Möllmann M; Montesinos-Rongen M; Heukamp L; Dürig J; Hallek M; Fingerle-Rowson G; Herling M
    Blood; 2013 May; 121(20):4126-36. PubMed ID: 23547049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IDO1-Targeted Therapy Does Not Control Disease Development in the Eµ-TCL1 Mouse Model of Chronic Lymphocytic Leukemia.
    Öztürk S; Kalter V; Roessner PM; Sunbul M; Seiffert M
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33920868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of CLL survival by hypoxia-inducible factor and its target genes.
    Shachar I; Cohen S; Marom A; Becker-Herman S
    FEBS Lett; 2012 Aug; 586(18):2906-10. PubMed ID: 22841548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of GRP78, HIF-1α and BAG3 Expression with the Severity of Chronic Lymphocytic Leukemia.
    Ijabi R; Roozehdar P; Afrisham R; Moradi-Sardareh H; Kaviani S; Ijabi J; Sahebkar A
    Anticancer Agents Med Chem; 2020; 20(4):429-436. PubMed ID: 31823704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factor.
    Reinart N; Nguyen PH; Boucas J; Rosen N; Kvasnicka HM; Heukamp L; Rudolph C; Ristovska V; Velmans T; Mueller C; Reiners KS; von Strandmann EP; Krause G; Montesinos-Rongen M; Schlegelberger B; Herling M; Hallek M; Fingerle-Rowson G
    Blood; 2013 Jan; 121(5):812-21. PubMed ID: 23118218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NcoA2-Dependent Inhibition of HIF-1α Activation Is Regulated via AhR.
    Tsai CH; Li CH; Liao PL; Cheng YW; Lin CH; Huang SH; Kang JJ
    Toxicol Sci; 2015 Dec; 148(2):517-30. PubMed ID: 26350169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting HIF-1α Regulatory Pathways as a Strategy to Hamper Tumor-Microenvironment Interactions in CLL.
    Vitale C; Griggio V; Riganti C; Todaro M; Kopecka J; Jones R; Salvetti C; Boccellato E; Perutelli F; Voena C; Godio L; Boccadoro M; Coscia M
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34207596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-Analysis Reveals Significant Sex Differences in Chronic Lymphocytic Leukemia Progression in the
    Koch M; Reinartz S; Saggau J; Knittel G; Rosen N; Fedorchenko O; Thelen L; Barthel R; Reinart N; Seeger-Nukpezah T; Reinhardt HC; Hallek M; Nguyen PH
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32698538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Specific CD44lo CD25lo Subpopulation of Regulatory T Cells Inhibits Anti-Leukemic Immune Response and Promotes the Progression in a Mouse Model of Chronic Lymphocytic Leukemia.
    Goral A; Firczuk M; Fidyt K; Sledz M; Simoncello F; Siudakowska K; Pagano G; Moussay E; Paggetti J; Nowakowska P; Gobessi S; Barankiewicz J; Salomon-Perzynski A; Benvenuti F; Efremov DG; Juszczynski P; Lech-Maranda E; Muchowicz A
    Front Immunol; 2022; 13():781364. PubMed ID: 35296093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of caveolin-1 leads to delayed development of chronic lymphocytic leukemia in Eμ-TCL1 mouse model.
    Shukla A; Cutucache CE; Sutton GL; Pitner MA; Rai K; Rai S; Opavsky R; Swanson PC; Joshi SS
    Exp Hematol; 2016 Jan; 44(1):30-7.e1. PubMed ID: 26435347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive activation of Lyn kinase enhances BCR responsiveness, but not the development of CLL in Eµ-TCL1 mice.
    Kohlhas V; Hallek M; Nguyen PH
    Blood Adv; 2020 Dec; 4(24):6106-6116. PubMed ID: 33351104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic alterations in a murine model for chronic lymphocytic leukemia.
    Chen SS; Sherman MH; Hertlein E; Johnson AJ; Teitell MA; Byrd JC; Plass C
    Cell Cycle; 2009 Nov; 8(22):3663-7. PubMed ID: 19901553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active Hexose-Correlated Compound Shows Direct and Indirect Effects against Chronic Lymphocytic Leukemia.
    Merchand-Reyes G; Santhanam R; Valencia-Pena ML; Kumar K; Mo X; Belay T; Woyach JA; Mundy-Bosse B; Tridandapani S; Butchar JP
    Nutrients; 2023 Dec; 15(24):. PubMed ID: 38140397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.